Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep

被引:5
作者
Carceles, Carlos M. [1 ]
Escudero, Elisa [1 ]
Fernandez-Varon, Emilio [1 ]
Marin, Pedro [1 ]
机构
[1] Univ Murcia, Fac Vet Med, Dept Pharmacol, Murcia 30071, Spain
关键词
Fluoroquinolones; Moxifloxacin; Pharmacokinetics; Sheep; Bioavailability; MILK PENETRATION; LACTATING GOATS; PHARMACODYNAMIC INTEGRATION; DANOFLOXACIN; FLUOROQUINOLONES; ENROFLOXACIN; DISPOSITION; DIFLOXACIN; ANIMALS; RABBITS;
D O I
10.1016/j.tvjl.2007.11.025
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The disposition kinetics of moxifloxacin, a fluoroquinolone antibiotic, after intravenous (IV), intramuscular (IM) and subcutaneous (SC) administration was determined in sheep at a single dose of 5 mg/kg. The concentration-time data were analysed by compartmental (after IV dose) and non-compartmental (after IV, IM and SC administration) pharmacokinetic methods. Plasma concentrations of moxifloxacin were determined by high performance liquid chromatography with fluorescence detection. steady-state volume of distribution (V-ss) and clearance (CI) of moxifloxacin after IV administration were 2.03 +/- 0.36 L/kg and 0.39 +/- 0.04 L/h kg, respectively. Following IM and SC administration. moxifloxacin achieved maximum plasma concentration of 1.66 +/- 0.62 mg/L and 0.90 +/- 0.19 mg/L at 2.25 +/- 0.88 h and 3.25 +/- 1.17 h, respectively. The absolute bioavailabilities after IM and SC routes were 96.12 +/- 32.70% and 102.20 +/- 23.76%, respectively. From these data (kinetic parameters and absence of adverse reactions) moxifloxacin may be a potentially useful antibiotic in sheep. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:343 / 347
页数:5
相关论文
共 37 条
[1]   Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids [J].
Aliabadi, FS ;
Landoni, MF ;
Lees, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :626-635
[2]   Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration [J].
Aliabadi, FS ;
Lees, P .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (12) :1979-1989
[3]   Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation [J].
AliAbadi, FS ;
Lees, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (04) :307-313
[4]   Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep [J].
Bermingham, EC ;
Papich, MG .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (07) :1012-1017
[5]  
Brogden KA, 1998, VET RES, V29, P233
[6]   Fluoroquinolones in animal health [J].
Brown, SA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (01) :1-14
[7]   Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats [J].
Carceles, Carlos M. ;
Villamayor, Lucia ;
Escudero, Elisa ;
Marin, Pedro ;
Fernandez-Varon, Emilio .
VETERINARY JOURNAL, 2007, 173 (02) :452-455
[8]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[9]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[10]   Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits [J].
Fernandez-Varon, E. ;
Marin, P. ;
Escudero, E. ;
Vancraeynest, D. ;
Carceles, C. M. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2007, 30 (01) :18-24